Sean P. Nolan

Chairman at Istari Oncology

Sean P. Nolan brings an array of experience to the Istari board from his time as President and Chief Executive Officer, and as a member of the Board of Directors of AveXis, Inc. leading up to its acquisition by Novartis. Prior to Joining AveXis, he was the Chief Business Officer of InterMune, Inc., Chief Commercial Officer at Reata Pharmaceuticals, Inc. and held numerous management positions at Ovation Pharmaceuticals, Inc., which was acquired by H. Lundbeck A/S in March 2009.

Mr. Nolan holds a BA in biology from John Carroll University. Mr. Nolan currently serves on the board of directors of Aquinox Pharmaceuticals, Inc. and serves as Chairman of Encoded Therapeutics.

Location

Chicago, United States

Links


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Istari Oncology

Istari Oncology, Inc. is a clinical-stage biotechnology company focused on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors.


Industries

Employees

11-50

Links